{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:26:18Z","timestamp":1790803578754,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jocn.2026.112076","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:56:26Z","timestamp":1778864186000},"page":"112076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Update on the management of leptomeningeal disease in solid organ malignancy: Systemic, intrathecal and novel therapies"],"prefix":"10.1016","volume":"151","author":[{"given":"Sanlin","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Topp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Airth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Stylli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hovens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2026.112076_b0005","article-title":"A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.jocn.2026.112076_b0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/cancers15030685","article-title":"The evolving landscape of leptomeningeal cancer from solid tumors: a systematic review of clinical trials","volume":"15","author":"Marenco-Hillembrand","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jocn.2026.112076_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000507","article-title":"How we treat patients with leptomeningeal metastases","volume":"4","author":"Le Rhun","year":"2019","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.jocn.2026.112076_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11910-025-01412-y","article-title":"Leptomeningeal disease: current approaches and future directions","volume":"25","author":"Sener","year":"2025","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jocn.2026.112076_b0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11060-022-04118-0","article-title":"Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials","volume":"160","author":"Palmisciano","year":"2022","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2026.112076_b0030","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/neuonc\/noz201","article-title":"Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer","volume":"22","author":"Le Rhun","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102653","article-title":"Pharmacotherapy for leptomeningeal disease in breast cancer","volume":"122","author":"Bartsch","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jocn.2026.112076_b0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41571-024-00970-3","article-title":"Leptomeningeal metastatic disease: new frontiers and future directions","volume":"22","author":"Ozair","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0045","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2026.112076_b0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.jocn.2026.112076_b0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.jocn.2026.112076_b0060","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.24.00708","article-title":"Phase II efficacy and safety of 80 mg osimertinib in patients with leptomeningeal metastases associated with EGFR mutation-positive non-small cell lung cancer (BLOSSOM)","volume":"42","author":"Park","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0065","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.annonc.2020.06.017","article-title":"A phase II, multicentre, two-cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy","volume":"31","author":"Park","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0070","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jtho.2021.04.018","article-title":"Efficacy and safety of intrathecal pemetrexed combined with dexamethasone for treating TKI-failed leptomeningeal metastases from EGFR-mutant NSCLC: a prospective phase 1\/2 clinical trial","volume":"16","author":"Fan","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0075","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/jjco\/hyab155","article-title":"Clinical efficacy and safety of different doses of intrathecal methotrexate in leptomeningeal carcinomatosis: a prospective study","volume":"51","author":"Hou","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102384","article-title":"Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: phase II trial","volume":"9","author":"Fan","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.jocn.2026.112076_b0085","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.cllc.2022.11.011","article-title":"Safety, pharmacokinetic and clinical activity of intrathecal pemetrexed via Ommaya reservoir","volume":"24","author":"Li","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jocn.2026.112076_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109740","article-title":"Concurrent involved-field radiotherapy and intrathecal chemotherapy for leptomeningeal metastasis","volume":"186","author":"Pan","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/neuonc\/noac195","article-title":"Intrathecal trastuzumab in HER2-positive cancer with leptomeningeal metastases","volume":"25","author":"Kumthekar","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0100","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41591-022-02170-x","article-title":"Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease","volume":"29","author":"Glitza Oliva","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jocn.2026.112076_b0105","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/cancers13122888","article-title":"Leptomeningeal metastases from solid tumors: recent advances","volume":"13","author":"Pellerino","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jocn.2026.112076_b0110","article-title":"EANO-ESMO clinical practice guidelines","volume":"28","author":"Le Rhun","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41568-024-00700-y","article-title":"The path to leptomeningeal metastasis","volume":"24","author":"Remsik","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jocn.2026.112076_b0120","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/neuonc\/noae103","article-title":"SNO\u2013ASCO consensus review on leptomeningeal metastases","volume":"26","author":"Wilcox","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0125","article-title":"EANO-ESMO clinical practice guideline update","volume":"8","author":"Le Rhun","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.jocn.2026.112076_b0130","article-title":"Treatment of brain metastases from NSCLC","volume":"14","author":"Sampat","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0135","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1200\/JCO.19.00457","article-title":"Osimertinib in EGFR-mutant NSCLC with leptomeningeal metastases (BLOOM)","volume":"38","author":"Yang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated EGFR-mutated NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2026.112076_b0145","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1200\/JCO.2018.77.9363","article-title":"CNS efficacy of osimertinib in AURA3","volume":"36","author":"Wu","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0150","article-title":"Intrathecal pemetrexed meta-analysis","volume":"15","author":"Zhao","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2026.112076_b0155","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.30214","article-title":"Radiotherapy and intrathecal methotrexate for leptomeningeal metastasis","volume":"139","author":"Pan","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jocn.2026.112076_b0160","first-page":"3394","article-title":"Sustained-release cytarabine vs methotrexate in neoplastic meningitis","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:35:01Z","timestamp":1790638501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826002274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S0967586826002274"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112076","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the management of leptomeningeal disease in solid organ malignancy: Systemic, intrathecal and novel therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112076"}}